Different effects of protamine on canine coronary microvessel and conductance arteries: Evidence of hyperpolarizing factor release

David G. Cable, Paul Sorajja, Marilyn R. Oeltjen, Hartzell V Schaff

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background. Protamine administration may lead to systemic hypotension, perhaps because of vasodilatation produced by endothelial nitric oxide. This study compared release of vasoactive substances from canine coronary microvessels with that from paired conductance arteries. Methods. Microvessels were mounted in a videoscopic no-flow system, and circumflex arteries were studied in organ chambers; both were induced to contract by endothelin-1. Results. Protamine (10 to 160 μg/mL) produced concentration- dependent relaxation in both microvessel and conductance arteries (46% ± 14% maximal relaxations in microvessel and 82% ± 15% in conductance arteries, n = 10 each). Removal of the endothelium abolished this relaxation (P < .05, n = 6). Indomethacin (10-5 mol/L) did not alter the relaxation in either group (51% ± 10% in microvessel and 103% ± 7% in conductance arteries, n = 6 each). N(G)-monomethyl-L-arginine (L-NMMA, 10-4 mol/L) attenuated relaxation in conductance arteries (38% ± 12%, p = .04, n = 6) but had no effect on microvessel arteries (58% ± 10%, n = 6). Tetraethylammonium chloride (10-3 mol/L), an inhibitor of voltage-dependent potassium channels, had no effect on conductance arteries (103% ± 9%, n = 6) but abolished relaxation in microvessels (-25% ± 11%, P =.03, n = 6). Conclusions. Protamine sulfate causes endothelium-dependent relaxation in microvessel and conductance arteries in the heart by different mechanisms - that is, by nitric oxide release in conductance arteries and by endothelium- derived hyperpolarizing factor (EDHF) release in microvessels. This is the first description of the release of EDHF in response to protamine administration.

Original languageEnglish (US)
Pages (from-to)835-841
Number of pages7
JournalSurgery
Volume126
Issue number5
DOIs
StatePublished - 1999

Fingerprint

Protamines
Microvessels
Canidae
Arteries
Endothelium
Nitric Oxide
omega-N-Methylarginine
Tetraethylammonium
Potassium Channels
Endothelin-1
Vasodilation
Indomethacin
Hypotension
Arginine

ASJC Scopus subject areas

  • Surgery

Cite this

Different effects of protamine on canine coronary microvessel and conductance arteries : Evidence of hyperpolarizing factor release. / Cable, David G.; Sorajja, Paul; Oeltjen, Marilyn R.; Schaff, Hartzell V.

In: Surgery, Vol. 126, No. 5, 1999, p. 835-841.

Research output: Contribution to journalArticle

@article{fe4d4e3aa0b74dc0a5a9636ac9275685,
title = "Different effects of protamine on canine coronary microvessel and conductance arteries: Evidence of hyperpolarizing factor release",
abstract = "Background. Protamine administration may lead to systemic hypotension, perhaps because of vasodilatation produced by endothelial nitric oxide. This study compared release of vasoactive substances from canine coronary microvessels with that from paired conductance arteries. Methods. Microvessels were mounted in a videoscopic no-flow system, and circumflex arteries were studied in organ chambers; both were induced to contract by endothelin-1. Results. Protamine (10 to 160 μg/mL) produced concentration- dependent relaxation in both microvessel and conductance arteries (46{\%} ± 14{\%} maximal relaxations in microvessel and 82{\%} ± 15{\%} in conductance arteries, n = 10 each). Removal of the endothelium abolished this relaxation (P < .05, n = 6). Indomethacin (10-5 mol/L) did not alter the relaxation in either group (51{\%} ± 10{\%} in microvessel and 103{\%} ± 7{\%} in conductance arteries, n = 6 each). N(G)-monomethyl-L-arginine (L-NMMA, 10-4 mol/L) attenuated relaxation in conductance arteries (38{\%} ± 12{\%}, p = .04, n = 6) but had no effect on microvessel arteries (58{\%} ± 10{\%}, n = 6). Tetraethylammonium chloride (10-3 mol/L), an inhibitor of voltage-dependent potassium channels, had no effect on conductance arteries (103{\%} ± 9{\%}, n = 6) but abolished relaxation in microvessels (-25{\%} ± 11{\%}, P =.03, n = 6). Conclusions. Protamine sulfate causes endothelium-dependent relaxation in microvessel and conductance arteries in the heart by different mechanisms - that is, by nitric oxide release in conductance arteries and by endothelium- derived hyperpolarizing factor (EDHF) release in microvessels. This is the first description of the release of EDHF in response to protamine administration.",
author = "Cable, {David G.} and Paul Sorajja and Oeltjen, {Marilyn R.} and Schaff, {Hartzell V}",
year = "1999",
doi = "10.1016/S0039-6060(99)70023-1",
language = "English (US)",
volume = "126",
pages = "835--841",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Different effects of protamine on canine coronary microvessel and conductance arteries

T2 - Evidence of hyperpolarizing factor release

AU - Cable, David G.

AU - Sorajja, Paul

AU - Oeltjen, Marilyn R.

AU - Schaff, Hartzell V

PY - 1999

Y1 - 1999

N2 - Background. Protamine administration may lead to systemic hypotension, perhaps because of vasodilatation produced by endothelial nitric oxide. This study compared release of vasoactive substances from canine coronary microvessels with that from paired conductance arteries. Methods. Microvessels were mounted in a videoscopic no-flow system, and circumflex arteries were studied in organ chambers; both were induced to contract by endothelin-1. Results. Protamine (10 to 160 μg/mL) produced concentration- dependent relaxation in both microvessel and conductance arteries (46% ± 14% maximal relaxations in microvessel and 82% ± 15% in conductance arteries, n = 10 each). Removal of the endothelium abolished this relaxation (P < .05, n = 6). Indomethacin (10-5 mol/L) did not alter the relaxation in either group (51% ± 10% in microvessel and 103% ± 7% in conductance arteries, n = 6 each). N(G)-monomethyl-L-arginine (L-NMMA, 10-4 mol/L) attenuated relaxation in conductance arteries (38% ± 12%, p = .04, n = 6) but had no effect on microvessel arteries (58% ± 10%, n = 6). Tetraethylammonium chloride (10-3 mol/L), an inhibitor of voltage-dependent potassium channels, had no effect on conductance arteries (103% ± 9%, n = 6) but abolished relaxation in microvessels (-25% ± 11%, P =.03, n = 6). Conclusions. Protamine sulfate causes endothelium-dependent relaxation in microvessel and conductance arteries in the heart by different mechanisms - that is, by nitric oxide release in conductance arteries and by endothelium- derived hyperpolarizing factor (EDHF) release in microvessels. This is the first description of the release of EDHF in response to protamine administration.

AB - Background. Protamine administration may lead to systemic hypotension, perhaps because of vasodilatation produced by endothelial nitric oxide. This study compared release of vasoactive substances from canine coronary microvessels with that from paired conductance arteries. Methods. Microvessels were mounted in a videoscopic no-flow system, and circumflex arteries were studied in organ chambers; both were induced to contract by endothelin-1. Results. Protamine (10 to 160 μg/mL) produced concentration- dependent relaxation in both microvessel and conductance arteries (46% ± 14% maximal relaxations in microvessel and 82% ± 15% in conductance arteries, n = 10 each). Removal of the endothelium abolished this relaxation (P < .05, n = 6). Indomethacin (10-5 mol/L) did not alter the relaxation in either group (51% ± 10% in microvessel and 103% ± 7% in conductance arteries, n = 6 each). N(G)-monomethyl-L-arginine (L-NMMA, 10-4 mol/L) attenuated relaxation in conductance arteries (38% ± 12%, p = .04, n = 6) but had no effect on microvessel arteries (58% ± 10%, n = 6). Tetraethylammonium chloride (10-3 mol/L), an inhibitor of voltage-dependent potassium channels, had no effect on conductance arteries (103% ± 9%, n = 6) but abolished relaxation in microvessels (-25% ± 11%, P =.03, n = 6). Conclusions. Protamine sulfate causes endothelium-dependent relaxation in microvessel and conductance arteries in the heart by different mechanisms - that is, by nitric oxide release in conductance arteries and by endothelium- derived hyperpolarizing factor (EDHF) release in microvessels. This is the first description of the release of EDHF in response to protamine administration.

UR - http://www.scopus.com/inward/record.url?scp=0032740455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032740455&partnerID=8YFLogxK

U2 - 10.1016/S0039-6060(99)70023-1

DO - 10.1016/S0039-6060(99)70023-1

M3 - Article

C2 - 10568182

AN - SCOPUS:0032740455

VL - 126

SP - 835

EP - 841

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 5

ER -